Back to mobile site

Cantor Fitzgerald Starts Evolent Health (EVH) at Overweight

January 5, 2017 4:26 PM EST
Get Alerts EVH Hot Sheet
Price: $4.55 -0.66%

Rating Summary:
    20 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE

Cantor Fitzgerald initiates coverage on Evolent Health (NYSE: EVH) with a Overweight rating and a price target of $26.00.

Analyst Steven Halper commented, "We initiate coverage of Evolent Health with an Overweight rating and $26 PT in 12 months. EVH’s population health management tools allow healthcare organizations to transition to value-based reimbursement. Its primary customers include captive health insurance plans of large, integrated delivery networks. Given the ongoing shift to value-based reimbursement, we believe EVH is well positioned to grow rapidly given the large addressable market. Despite some concerns about the future of the Affordable Care Act (ACA), we believe market forces will continue to drive the shift to value-based reimbursement in many large population markets."

For an analyst ratings summary and ratings history on Evolent Health click here. For more ratings news on Evolent Health click here.

Shares of Evolent Health closed at $15.20 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

Cantor Fitzgerald